In addition to helping diabetics with insulin resistance issues, each of these injectables gained popularity in recent years because of their ability to facilitate weight loss
PubMed , Lffler, Dennis, et al
Compound Retatrutide Total strength 40mg Format Single pre-filled pen Brand Alluvi Batch AR1739JAT Stock In stock in the UK Documentation Janoshik report available Intended listing Laboratory research use only Documentation and handling notes Documentation Review the Alluvi product gallery, pack details, current stock status and available quality information before placing a research order

Insurance concierge: Hands-on support to navigate coverage for Ozempic, Wegovy, and Zepbound Labs included: Diagnostic testing included to tailor dosing and safety checks Medication choice: Access to brand-name GLP-1s and compounded alternatives when appropriate Personalized plans: Protocols customized to your lab results, history, and tolerance Flexible app-based care: Ongoing telehealth with no long-term commitment Lifestyle coaching: Built-in guidance for nutrition, habits, and sustainable change Heads up on common pitfalls elsewhere: some programs bill quarterly up front, exclude medication costs, offer only injectables, rely on nurse-led coaching, and use compounded GLP-1s that are not FDA-approved or available in every state
IUPHAR reviewglucagon-like peptide-1 (GLP-1) and substance use disorders: an emerging pharmacotherapeutic target
Before comparing them, one fact has to sit at the front: as of mid-2026, neither cagrilintide nor retatrutide is approved by the U.S